Else Nutrition to Participate in the Lytham Partners Winter 2021 Investor Conference
December 07 2021 - 7:00AM
ELSE NUTRITION HOLDINGS INC.
(TSX-V: BABY)
(OTCQB: BABYF) (FSE: 0YL)
(“
Else” or the
“
Company”
), the plant-based
baby, toddler and children nutrition company, announced
today that it will be participating in the Lytham Partners Winter
2021 Investor Conference taking place from December 13-16, 2021.
During the event, the company will be participating in a webcasted
Fireside Chat discussing its vision for 2022 and conducting 1x1
virtual investor meetings.
The webcasted Fireside Chat will be available for viewing at
11:00am ET on Monday, December 13, 2021 on the Company's website at
https://elsenutrition.com/pages/investor-relations or
https://wsw.com/webcast/lytham3/babyf/2166600. The webcast will
also be available for replay following the event.
To arrange a 1x1 meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register at
www.lythampartners.com/winter2021invreg.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the “2017 Best Health and Diet
Solutions” award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The holding company, Else Nutrition Holdings
Inc., is a publicly traded company, listed as TSX Venture Exchange
under the trading symbol BABY and is quoted on the US OTC Markets
QX board under the trading symbol BABYF and on the Frankfurt
Exchange under the symbol 0YL. Else’s Executives include leaders
hailing from leading infant nutrition companies. Many of Else
advisory board members had past executive roles in companies such
as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant
nutrition Societies, and some of them currently serve in different
roles in leading medical centers and academic institutes such as
Boston Children’s Hospital, Pediatrics at Harvard Medical School,
USA, Tel Aviv University, Schneider Children’s Medical Center of
Israel, Rambam Medical Center and Technion, Israel and University
Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Media ContactErin JundefBrilliant
PRerinj@brilliantpr.com
For more information, contact:
Mrs. Hamutal Yitzhak, CEO, Co-Founder &
DirectorELSE Nutrition Holdings Inc.E: hamutaly@elsenutrition.comP:
+972(0)3-6445095
Mr. Sokhie Puar, Director of Else NutritionE:
sokhiep@elsenutrition.comP: 604-603-7787
US Investor Relations Contact:
Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
TSX Venture Exchange
Neither the TSX Venture Exchange nor its
regulation services provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will”, “expect” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such
forward-looking statements reflect current estimates, beliefs and
assumptions, which are based on management’s perception of current
conditions and expected future developments, as well as other
factors management believes are appropriate in the circumstances.
No assurance can be given that the foregoing will prove to be
correct. Forward-looking statements made in this press release
assume, among others, the expectation that listing on the FSE will
create additional liquidity and attract additional investors in the
European market. Actual results may differ from the estimates,
beliefs and assumptions expressed or implied in the forward-looking
statements. Readers are cautioned not to place undue
reliance on any forward-looking statements, which reflect
management’s expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Else Nutrition (TSXV:BABY)
Historical Stock Chart
From Oct 2023 to Oct 2024